StockData
NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31

NERVGEN PHARMA CORP.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026
$1.54−0.05 (-3.14%)

Close on Oct 19, 2026

Price history

Daily open, high, low, close and volume

DateOpenHighLowCloseChangeVolume
Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected.

Stock splits

From SEC filings

No stock splits found in NGEN's filings.